Literature DB >> 28798509

Pharmacokinetics of apixaban.

Penny Beirne1.   

Abstract

Entities:  

Year:  2017        PMID： 28798509      PMCID： PMC5478397          DOI： 10.18773/austprescr.2017.033

Source DB:  PubMed          Journal:  Aust Prescr        ISSN： 0312-8008


× No keyword cloud information.
  5 in total

Review 1.  Long-term prescribing of new oral anticoagulants.

Authors:  Paul Kl Chin; Matthew P Doogue
Journal:  Aust Prescr       Date:  2016-12-05

2.  Inconsistencies in reporting of renal elimination among NOACs: the case of apixaban.

Authors:  Maja Hellfritzsch; Per Damkier; Anton Pottegård; Thor Grønlykke; Erik L Grove
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-03       Impact factor: 2.890

3.  Effect of Rifampin on the Pharmacokinetics of Apixaban, an Oral Direct Inhibitor of Factor Xa.

Authors:  Blisse Vakkalagadda; Charles Frost; Wonkyung Byon; Rebecca A Boyd; Jessie Wang; Donglu Zhang; Zhigang Yu; Clapton Dias; Andrew Shenker; Frank LaCreta
Journal:  Am J Cardiovasc Drugs       Date:  2016-04       Impact factor: 3.571

4.  Apixaban metabolism and pharmacokinetics after oral administration to humans.

Authors:  Nirmala Raghavan; Charles E Frost; Zhigang Yu; Kan He; Haiying Zhang; W Griffith Humphreys; Donald Pinto; Shiangyuan Chen; Samuel Bonacorsi; Pancras C Wong; Donglu Zhang
Journal:  Drug Metab Dispos       Date:  2008-10-02       Impact factor: 3.922

5.  The contribution of apixaban renal clearance to total clearance.

Authors:  Charles Frost; Rebecca A Boyd
Journal:  J Thromb Thrombolysis       Date:  2015-11       Impact factor: 2.300
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.